These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8884682)

  • 41. [Chronic pain--new patch size expands therapy spectrum].
    MMW Fortschr Med; 2004 Dec; 146(49):56-7. PubMed ID: 15646722
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic narcotics in the workplace.
    J Occup Med; 1989 Jul; 31(7):583. PubMed ID: 2570138
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
    Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
    J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Conservative treatment of chronic low back pain: what is new in 2008?].
    Balagué F; Ochoa Amaya G; Genevay S
    Rev Med Suisse; 2009 Mar; 5(194):560-2, 564. PubMed ID: 19405270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Updates on managing acute and chronic pain in primary care practice--optimizing pain reduction, minimizing adverse events.
    McCarberg BH; Adler JA
    JAAPA; 2008 Oct; Suppl Pain():1-13. PubMed ID: 19097289
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of medications in the treatment of acute low back pain.
    Malanga GA; Dennis RL
    Clin Occup Environ Med; 2006; 5(3):643-53, vii. PubMed ID: 16963380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain.
    Wang H; Akbar M; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Med; 2011 Dec; 12(12):1720-6. PubMed ID: 22082225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher doses of pain medication linked to psychiatric problems.
    J Gerontol Nurs; 2013 Feb; 39(2):8. PubMed ID: 23460951
    [No Abstract]   [Full Text] [Related]  

  • 50. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.
    Wen W; Sitar S; Lynch SY; He E; Ripa SR
    Expert Opin Pharmacother; 2015; 16(11):1593-606. PubMed ID: 26111544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Patient with chronic backache. Disabled or muscle spasm patient?].
    MMW Fortschr Med; 2002 Dec; 144(49):61. PubMed ID: 12577750
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.
    Wild JE; Grond S; Kuperwasser B; Gilbert J; McCann B; Lange B; Steup A; Häufel T; Etropolski MS; Rauschkolb C; Lange R
    Pain Pract; 2010; 10(5):416-27. PubMed ID: 20602712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shorter time between opioid prescriptions associated with reduced work disability among acute low back pain opioid users.
    Cifuentes M; Powell R; Webster B
    J Occup Environ Med; 2012 Apr; 54(4):491-6. PubMed ID: 22441492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update in pain medicine.
    Alford DP; Krebs EE; Chen IA; Nicolaidis C; Bair MJ; Liebschutz J
    J Gen Intern Med; 2010 Nov; 25(11):1222-6. PubMed ID: 20632120
    [No Abstract]   [Full Text] [Related]  

  • 56. Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain.
    Wallace M; Thipphawong J
    Pain Med; 2010 Oct; 11(10):1477-88. PubMed ID: 21199302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.
    Schiltenwolf M; Akbar M; Hug A; Pfüller U; Gantz S; Neubauer E; Flor H; Wang H
    Pain Physician; 2014; 17(1):9-20. PubMed ID: 24452649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ergonomics: The only way.
    Paul E
    Br Dent J; 2014 Dec; 217(11):613. PubMed ID: 25476617
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of tramadol in treatment of chronic low back pain.
    Schnitzer TJ; Gray WL; Paster RZ; Kamin M
    J Rheumatol; 2000 Mar; 27(3):772-8. PubMed ID: 10743823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain.
    Rauck RL; Potts J; Xiang Q; Tzanis E; Finn A
    Postgrad Med; 2016 Jan; 128(1):1-11. PubMed ID: 26634956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.